Two Pharmaceutical Companies Update IPO Prospectuses in Race for Billion-Dollar IPOs on HKEX

June 10, 2026

In the wake of a surge in IPO activities by innovative pharmaceutical companies on the Hong Kong Stock Exchange (HKEX) since 2026, companies like Maywei Biopharma, Engpai Pharmaceuticals, and Danno Pharmaceuticals have successfully listed on the HKEX.…